HBIO · Harvard Bioscience Inc

$7.48 -0.07 (-0.93%) At close · Aug 21

Market Cap

$34.05M

4.55M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-11	2026-06-30
8-K	2026-08-11	—
8-K	2026-08-11	—
8-K	2026-06-02	—
8-K	2026-05-12	—
8-K	2026-05-12	—
10-Q	2026-05-12	2026-03-31
DEF 14A	2026-04-21	2026-06-02
8-K	2026-03-17	—
10-K	2026-03-13	2025-12-31
8-K	2026-03-12	—
8-K	2026-03-10	2026-03-06
8-K	2026-03-06	—
8-K	2026-02-10	—
DEF 14A	2026-01-30	2026-03-06
8-K	2026-01-29	2026-01-23
8-K	2026-01-20	2026-01-19
8-K	2026-01-12	—
8-K	2025-12-17	—
8-K	2025-12-05	—
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	—
8-K	2025-10-03	2025-10-02
8-K	2025-09-09	2025-09-05
8-K	2025-08-13	2025-08-12
8-K	2025-08-11	2025-08-08
8-K	2025-08-11	—
10-Q	2025-08-11	2025-06-30
8-K	2025-07-17	2025-07-16
8-K/A	2025-06-27	2025-06-18
8-K	2025-06-23	2025-06-18
8-K	2025-06-13	2025-06-10
8-K	2025-06-02	2025-05-30
8-K	2025-05-12	—
10-Q	2025-05-12	2025-03-31
DEF 14A	2025-04-21	2025-06-02
8-K	2025-04-16	2025-04-10
8-K	2025-04-10	—
10-K	2025-03-14	2024-12-31
8-K	2025-03-12	2025-03-10
8-K	2025-03-12	—
10-Q	2024-11-08	2024-09-30
8-K	2024-11-07	—
10-Q	2024-08-08	2024-06-30
8-K	2024-08-08	—
8-K	2024-05-14	—
10-Q	2024-05-07	2024-03-31
8-K	2024-05-07	—
DEF 14A	2024-04-03	2024-05-14
8-K	2024-04-03	2024-03-28

Showing 1–50 of 114 filings

Key facts CIK 1123494 CUSIP 416906204 13F (30d) 41 filings 34 filers Visit website Investor relations